HA-Cdk9 Citations (4)

Originally described in: Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-loop.
Wang Y, Dow EC, Liang YY, Ramakrishnan R, Liu H, Sung TL, Lin X, Rice AP J Biol Chem. 2008 Nov 28. 283(48):33578-84. PubMed Journal

---

Articles Citing HA-Cdk9

Articles
Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors. Joshi PM, Sutor SL, Huntoon CJ, Karnitz LM. J Biol Chem. 2014 Mar 28;289(13):9247-53. doi: 10.1074/jbc.M114.551143. Epub 2014 Feb 19. PubMed
The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, Schulze-Osthoff K, Kramer D. J Clin Invest. 2020 Jul 23. pii: 134217. doi: 10.1172/JCI134217. PubMed
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein-protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells. Cheng S, Yang GJ, Wang W, Ma DL, Leung CH. Genes Dis. 2021 Jul 10;9(6):1674-1688. doi: 10.1016/j.gendis.2021.06.005. eCollection 2022 Nov. PubMed
Piperlongumine conjugates induce targeted protein degradation. Pei J, Xiao Y, Liu X, Hu W, Sobh A, Yuan Y, Zhou S, Hua N, Mackintosh SG, Zhang X, Basso KB, Kamat M, Yang Q, Licht JD, Zheng G, Zhou D, Lv D. Cell Chem Biol. 2023 Feb 16;30(2):203-213.e17. doi: 10.1016/j.chembiol.2023.01.004. Epub 2023 Feb 6. PubMed

If you have published an article using this material, please email us at to have your article added to this page.